Biogenesis is not a drug scandal. THIS is a drug scandal.

82 Comments

Or at least an alleged one.

By way of disclaimer: I don’t offer this in my usual spirit of pumping up baseball at the expense of the NFL. This is way too serious a matter for that. And I hope like hell that the allegations here aren’t true. But if they are — if even part of them are — this would be a major, major story. One that could be far more serious for the NFL than the concussion thing:

A new class action has been filed against the NFL alleging that the league illegally used prescription pain-killers to mask injuries and to allow players to keep playing. The named plaintiffs include Bears Hall of Fame defensive end Richard Dent and former Bears quarterback Jim McMahon.

The allegations include claims that teams would conceal the diagnosis of injuries from players, pump them up with drugs and send them back on the field. Injuries like actual broken bones. McMahon claims that his teams doing them led him into a severe prescription drug addiction. Mike Florio has context about the legal hurdles the players have before them and talks about the complexities of it all here. Given Mike’s legal background, if this story is of interest to you, be sure to follow at PFT.

In any event, if these allegations are borne out, it makes Biogenesis, BALCO and any other drug scandal we’ve seen in sports look like child’s play. I mean, it’s one thing when some rogue athletes willingly take some things they shouldn’t in an effort to get healthy again following an injury. It’s another thing altogether for the league itself to be involved in a pattern of behavior in which players are given drugs for the specific purpose of getting injured bodies back on the field before they have a chance to get healthy. Against their will and without their knowledge if the allegations here are true.

Here’s hoping that, unlike with any of the other drug scandals in sports, this one is treated with the amount of gravity it is actually owed.

Watch: Mike Trout ties MLB record with his 25th home run

Getty Images
Leave a comment

It was only a matter of time before Mike Trout courted another all-time record, and on Saturday, he found himself in elite company with his 25th and 26th home runs of the season. He put the Angels on the board with a 429-foot blast in the first inning, depositing an 0-1 fastball from the Orioles’ Kevin Gausman into the left field bleachers:

In the third inning, with the Angels up 2-1, Trout returned to tack on another insurance run. He targeted Gausman’s slider for his second solo shot of the evening and cleared the center field fence with a 418-footer to bring his total to 26 home runs on the year.

Trout has mashed at a staggering .339/.471/.596 clip since his return from the disabled list last month, and Saturday’s totals helped mark his sixth consecutive season with at least 25 home runs. That’s a record few have matched before their age-26 season; in fact, only Hall of Fame sluggers Eddie Mathews and Frank Robinson have ever pulled it off.

Assuming he continues to rake in hits and plate appearances over the last six weeks of the regular season — and there’s nothing to indicate that he won’t — Trout is in line to join elite company of a different kind. The 26-year-old entered Saturday’s game with a 206 OPS+ (park-adjusted on-base plus slugging). According to MLB.com’s Matt Kelly, that means Trout’s hitting at a better clip than the average Major League player by a full 106 percent. Should he finish the year with a 200 OPS+ and 502 plate appearances or better, he’ll be the first player to do so since Barry Bonds obliterated the competition with his 263 OPS+ in 2004.

Blue Jays acquire Tom Koehler from Marlins

Getty Images
Leave a comment

The Blue Jays acquired right-hander Tom Koehler from the Marlins in exchange for minor league right-hander Osman Gutierrez and cash considerations, the clubs announced Saturday. Koehler is in his sixth year with the Marlins and stands to make $5.75 million in 2017. He’ll be arbitration eligible in 2018 and is set to enter free agency by 2019.

The 31-year-old right-hander struggled to a 7.92 ERA, 4.7 BB/9 and 7.1 SO/9 over 55 2/3 innings with Miami in 2017. He was optioned to Triple-A New Orleans in late July, where he rebounded with a 1-1 record in seven starts and whittled his ERA down to a 1.67 mark. The Blue Jays have yet to establish Koehler’s role within their organization, but are hoping to see a turnaround from the righty when he breaks back into the big leagues.

Gutierrez, 22, was assigned to Single-A Greensboro on Saturday. He has yet to find his footing in the minors, and exited a 78-inning stint with Single-A Lansing after racking up a career-worst 7.85 ERA and 8.2 SO/9. His lack of control is particularly alarming, with a 6.2 BB/9 that dwarfs the 2.0+ BB/9 of seasons past, but he still has plenty of time to figure out his mechanics before reaching the Show.